However, reductions in TET2 expression and activity are unlikely to be due to TET2 mutations, as direct sequencing of TET2 revealed very few mutations and minimal association of mutations with levels of 5-hmC in gliomas (68, 69). The gene discussed is TET2; the disease is glioma.